Surgical Management: Open Surgical Treatment of Infra-Inguinal Occlusive Disease
Infra-inguinal occlusive disease in diabetic and non-diabetic patients without treatment carries a significant risk of minor and major amputation as well as death. There are different modalities in treating peripheral arterial disease including bypass surgery and angioplasty. Several investigations have studied the outcomes in both modalities. Hybrid techniques using different revascularisation strategies have also been used especially in complex and redo- cases.
In this chapter the authors are addressing the different diagnostic modalities in critical leg ischaemia and the planning of surgical treatment in these patients. The outcome of distal and ultra-distal bypass surgery in the literature is also examined and the means of improving bypass outcome and follow-up are highlighted. Finally the role of arterial bypass and other modalities is briefly discussed in the treatment of acute lower limb ischaemia.
KeywordsCritical ischaemia Bypass Angioplasty Amputation Wound healing Outcomes Mortality acute ischaemia
- 2.Bradbury AW, Adam DJ, Bell J, Forbes JF, Fowkes FG, Gillespie I, et al. on behalf of the BASIL trial Participants. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg 2010;51: 5S–17S.Google Scholar
- 3.Menard MT, Farber A, Assman SF, Choudhry NK, Conte MS, Creager MA, et al. Design and rationale of the best endovascular versus best surgical therapy for patients with critical limb ischemia (BEST-CLI). Trial J Am Heart Assoc. 2016;5(7):e003219. https://doi.org/10.1161/JAHA.116.003219.CrossRefPubMedGoogle Scholar
- 4.TASC. Management of peripheral arterial disease (PAD). Trans Atlantic Inter-Society Consensus (TASC). Eur J Vasc Endovasc Surg. 2000;19(Suppl A):Si-xxviii, S1–250.Google Scholar
- 5.Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR, on behalf of the TASC II Working Group. TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33 Suppl 1:S1–75.Google Scholar
- 6.Aboyans V, Ricco JB, Bartelink ML, Björck M, Brodmann M, Cohnert T, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in Collaboration With the European Society for Vascular Surgery (ESVS): Document Covering Atherosclerotic Disease of Extracranial Carotid and Vertebral, Mesenteric, Renal, Upper and Lower Extremity Arteries. Eur Heart J. 2018;39(9):763–816. https://doi.org/10.1093/eurheartj/ehx095.CrossRefPubMedGoogle Scholar
- 14.Gerhard-Herman, M. D., Gornik, H. L., Barrett, C., Barshes, N. R., Corriere, M. A., Drachman, D.E et al. (2016). 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2016; 135(12), e686-e725.Google Scholar
- 15.Treatment for Acute Limb Ischemia. J Vasc Surg. 2000;31(Suppl 1):S150–1. https://doi.org/10.1016/S0741-5214(00)81022-8.
- 20.Berridge DC, Kessel D, Robertson I. Surgery versus thrombolysis for acute limb ischaemia: initial management. Cochrane Database Syst Rev. 2002;(3):CDd002784.Google Scholar